Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed-Dose Combination Drugs
(2002; 81 pages) View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
View the documentLIST OF ACRONYMS AND ABBREVIATIONS
View the documentPREFACE
View the documentKEY POINTS
Open this folder and view contents1. INTRODUCTION
Open this folder and view contents2. PROGRAMMATIC AND MANAGERIAL REQUIREMENTS FOR FDCS
Open this folder and view contents3. FDC DRUG MANAGEMENT
Open this folder and view contents4. ENSURING THE QUALITY OF FDC DRUGS
Open this folder and view contents5. HOW TO INTRODUCE AND CHANGE OVER TO A REGIMEN WITH 4-DRUG FDCS/2-DRUG FDCS: PLANNING AND IMPLEMENTING A "SCENARIO"
View the documentAnnex 1. Glossary and use of terms
View the documentAnnex 2. WHO Certification Scheme - Model Certificate of a Pharmaceutical Product1
View the documentAnnex 3. WHO Certification Scheme - Model Batch Certificate of a Pharmaceutical Product
View the documentAnnex 4. Example of an order form for anti-TB drugs for treatment facilities
View the documentAnnex 5. Steps in the quantification of anti-TB drugs using consumption-based information
View the documentAnnex 6. Suggested reading
View the documentRequest for feedback on the guide
 

Operational Guide for National Tuberculosis Control Programmes on the Introduction and Use of Fixed-Dose Combination Drugs

WHO/CDS/TB/2002.308 - WHO/EDM/PAR/2002.6

WORLD HEALTH ORGANIZATION
2002

Writing Group

S. Phanouvong 1
H. Vrakking 2
L. Blanc 3
E. Wondemagegnehu 4
T. Moore 5
L. Rägo 6
J. Mboussa 7
P. Norval 8
R. Matji 9

1 Technical Officer, Focal Point for Access to Quality Anti-TB Medicines, Department of Essential Drugs and Medicines Policy and Stop TB Department (STB), WHO

2 Technical Officer, Royal Netherlands Anti-Tuberculosis Association (KNCV), The Hague, Netherlands

3 Medical Officer, Tuberculosis Strategy and Operations (TBS), Stop TB Department, WHO

4 Technical Officer, Department of Essential Drugs and Medicines Policy, WHO

5 Senior Programme Associate, Management Sciences for Health and Stop TB Department, Global TB Drug Facility, WHO

6 Team Coordinator, Quality Assurance and Safety: Medicines, Department of Essential Drugs and Medicines Policy, WHO

7 Director, Anti-tuberculosis Programme, Brazzaville, Congo.

8 Tuberculosis Expert, Ministry of Health, France

9 Manager, National Tuberculosis Control Programme, South Africa

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014